3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Tumor-Agnostic
1
Thoracic
1
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
1
Laryngeal Diseases
1
Head and Neck Neoplasms
1
Interventions
pembrolizumab
66
Cisplatin
55
Radiotherapy, Intensity-Modulated
28
Carboplatin
27
Nivolumab
26
Paclitaxel
21
Magnetic Resonance Spectroscopy
21
Radiotherapy
20
Cetuximab
16
Specimen Handling
15
Docetaxel
15
Radiation
14
Gemcitabine
13
Fluorouracil
12
Biopsy
12
durvalumab
11
Platinum
11
Taxes
10
Drug Therapy
10
1,2-diaminocyclohexaneplatinum II citrate
10
Surveys and Questionnaires
9
Capecitabine
9
trametinib
8
tislelizumab
6
lenvatinib
6
dabrafenib
6
cemiplimab
6
atezolizumab
6
Radiosurgery
6
Ipilimumab
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
monalizumab
×
Head & Neck
×
Clear all
NCT04590963
2026-06-01
INTERLINK-1
AstraZeneca
Phase 3
Active not recruiting
370 enrolled
21 charts